QC
OGN icon

Quantessence Capital’s Organon & Co OGN Stock Holding History

Quantessence Capital’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,833
Closed -$76.9K – 115
2026
Q1 		$76.9K Buy
+12,833
New +$96.6K 0.37% 56
2025
Q2 		– Sell
-55,200
Closed -$822K – 369
2025
Q1 		$822K Buy
+55,200
New +$849K 0.21% 145

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Quantessence Capital's OGN Position: Q2 2026 in Review

Quantessence Capital sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 12,833 shares — an estimated $76.9K sold.

Quantessence Capital first reported a position in OGN in Q1 2025 and held it in 2 quarters. The position peaked at $822K in Q1 2025. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Quantessence Capital reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
  • Quantessence Capital sold 12,833 Organon & Co shares in Q2 2026, an estimated $76.9K.
  • Quantessence Capital first reported a position in Organon & Co in Q1 2025 and held it in 2 quarters.
  • Quantessence Capital's Organon & Co position peaked at $822K in Q1 2025.
  • 627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Quantessence Capital's 13F filing for Q2 2026, filed 14 Aug 2026.